Abstract

Background

Respiratory syncytial virus (RSV) is the most commonly identified viral pathogen among young children with acute lower respiratory tract infection. Understanding global RSV epidemiology and risk factors for severe illness in low- and middle-income settings is critical as new vaccine candidates become available.

Methods

We prospectively enrolled infants aged < 1 year hospitalized with any acute illness from sites in Albania, Jordan, Nicaragua and Philippines during 2015–2017. Standardized parental interviews and medical record review were conducted. Respiratory specimens collected during enrollment were tested for RSV using rRT–PCR. RSV A or B subgroup was determined using a CDC-developed rRT–PCR assay. Very severe RSV illness was defined as requiring ICU admission or supplemental oxygen. Factors potentially associated with severity were assessed using individual logistic regression models to adjust for age and study site.

Results

Overall, 1,129 (31%) of 3634 enrolled infants had RSV infection. The median age of RSV-positive infants was 2.7 (range: < 1 to 11.9) months, 665 (59%) were male, and 63 (6%) had ≥1 underlying medical condition. RSV subgroup was determined for 1,028 (91%); RSV A and B co-circulated at all sites with alternating predominance by study year (figure). 583 (52%) infants had very severe RSV illness, which was significantly associated with younger age (median: 2.0 vs. 4.3 months; P < 0.01), study site (aOR: Jordan 5.0, Albania 2.9, Philippines 1.2, Nicaragua reference; P < 0.01), birth by cesarean section (aOR: 1.4; 95% CI [CI] 1.0–1.8; P = 0.03), having received ICU care after birth (aOR: 1.6; CI 1.0–2.4; P = 0.03), chronic heart or respiratory tract disease (aOR: 1.9; CI 1.0–3.4; P = 0.04), and a low weight-for-age Z score (aOR: 1.8; CI 1.3–2.7; P < 0.01). RSV subgroup was not associated with severity (aOR: 1.0; CI: 0.7–1.3; P = 0.72).

Conclusion

RSV was associated with a substantial proportion of acute illness among hospitalized infants in middle-income countries. Subgroups co-circulated across sites and study years with varying predominance and resulted in similar illness severity. Significant comorbidities were uncommon, but factors including younger age, low weight-for-age and chronic heart or respiratory tract disease were associated with more severe illness.

Disclosures

All authors: No reported disclosures.

Details

Title
2629. Respiratory Syncytial Virus Epidemiology and Factors Associated with Severity among Hospitalized Infants in Four Middle-Income Countries, 2015–2017
Author
Biggs, Holly 1 ; Simoes, Eric A 2 ; Ilham Bulos Abu-Khader 3 ; Thompson, Mark G 4 ; Gordon, Aubree 5 ; Hunt, Danielle R 6 ; DeGroote, Nicholas 7 ; Whitaker, Brett L 8 ; Wang, Lijuan 7 ; Marar, Basima 9 ; Gresh, Lionel 10 ; de Jesus, Joanne 11 ; Silva Bino 12 ; Porter, Rachael M 13 ; McMorrow, Meredith 8 ; Campbell, William 6 ; Zhang, Yange 1 ; Lindstrom, Stephen 8 ; Thornburg, Natalie J 8 ; Langley, Gayle 1 ; Peret, Teresa C T 8 ; Simaku, Artan 12 ; Gerber, Susan I 8 

 CDC, Atlanta, Georgia 
 University of Colorado, Denver, Colorado 
 Eastern mediteranean Public Health Network, Jordan, ‘Amman, Jordan 
 US Centers for Disease Control and Prevention, Atlanta, Georgia 
 University of Michigan, Ann arbor, Michigan 
 Abt Associates, Atlanta, Georgia 
 Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 
 Centers for Disease Control and Prevention, Atlanta, Georgia 
 Al-Bashir Hospital, Amman, Jordan 
10  Sustainable Sciences Institute, Managua, Nicaragua 
11  Research Institute for Tropical Medicine, Department of Health, Muntinlupa City, National Capital Region, Philippines 
12  Institute of Public Health, Tirana, Tirane, Albania 
13  Centers for Disease Control and Prevention, Influenza Division, Atlanta, Georgia 
Pages
S917-S918
Publication year
2019
Publication date
Oct 2019
Publisher
Oxford University Press
e-ISSN
23288957
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3171069234
Copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.